Gemfibrozil
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
16714-101 -
Package NDC
16714-101-02 -
Package NDC
16714-101-05 -
Application number
ANDA079072 -
SPL ID
ff9c9bd0-e2a2-4e38-aa8b-16d215d36450 -
SPL set ID
75cac02c-56e3-4dfe-b1e2-4ce166b28833 -
UNII
Q8X02027X3 -
RxCUI
310459
What the source publishes
- Labeler
- Northstar RxLLC
- Active ingredients
- gemfibrozil
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Gemfibrozil",
"splId": "ff9c9bd0-e2a2-4e38-aa8b-16d215d36450",
"labels": [
{
"setId": "75cac02c-56e3-4dfe-b1e2-4ce166b28833",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75cac02c-56e3-4dfe-b1e2-4ce166b28833",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75cac02c-56e3-4dfe-b1e2-4ce166b28833"
}
],
"routes": [
"ORAL"
],
"labeler": "Northstar RxLLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (16714-101-02)",
"package_ndc": "16714-101-02",
"identifierStatus": "well-formed",
"marketing_end_date": "20261130",
"marketing_start_date": "20101220"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (16714-101-05)",
"package_ndc": "16714-101-05",
"identifierStatus": "well-formed",
"marketing_end_date": "20261231",
"marketing_start_date": "20101220"
}
],
"productId": "16714-101_ff9c9bd0-e2a2-4e38-aa8b-16d215d36450",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "16714-101",
"deaSchedule": null,
"genericName": "gemfibrozil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20261231",
"activeIngredients": [
{
"name": "GEMFIBROZIL",
"strength": "600 mg/1"
}
],
"applicationNumber": "ANDA079072",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20101220",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175596",
"N0000175375",
"M0543661"
],
"unii": [
"Q8X02027X3"
],
"rxcui": [
"310459"
],
"spl_set_id": [
"75cac02c-56e3-4dfe-b1e2-4ce166b28833"
],
"pharm_class_cs": [
"Fibric Acids [CS]"
],
"pharm_class_epc": [
"Peroxisome Proliferator Receptor alpha Agonist [EPC]"
],
"pharm_class_moa": [
"Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"
],
"manufacturer_name": [
"Northstar RxLLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:16714-101_ff9c9bd0-e2a2-4e38-aa8b-16d215d36450"